M. Brandely

Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy.

Éric Pujade-Lauraine, Jean‐Paul Guastalla, Nicoletta Colombo et al. · Journal of Clinical Oncology · 1996 · 160 citations

Medicine, Oncology, Surgery +15

Activity of intrapleural recombinant gamma-interferon in malignant mesothelioma

C Boutin, J. R. Viallat, Nico van Zandwijk et al. · Cancer · 1991 · 129 citations · Full text

Medicine, Oncology, Pathology +14

High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse

D Maraninchi, Didier Blaise, Patrice Viens et al. · Blood · 1991 · 94 citations · Full text

Medicine, Hematology, Oncology +14

Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours

Jos Kitzen, Maja J.A. de Jonge, C. B. H. W. Lamers et al. · European Journal of Cancer · 2009 · 90 citations

Life Sciences, Oncology, Pharmacology +14

Anti‐tumor and immunomodulatory activity of intraperitoneal IFN‐γ in ovarian carcinoma patients with minimal residual tumor after chemotherapy

Nicoletta Colombo, Fedro A. Peccatori, C Paganin et al. · International Journal of Cancer · 1992 · 79 citations

Life Sciences, Immunology, Oncology +17